(Q33234511)

English

Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

0 references

1 reference

Europe PubMed Central

Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Lise L Gluud

2

0 references

Christian Gluud

object named as

Christian Gluud

3

0 references

author name string

Jesper Brok

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

0 references

publication date

22 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

842-847

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Evaluation of ribavirin efficacy and tolerance in subjects with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Quantifying adverse drug events : are systematic reviews the answer?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Teratogenic effects of ribavirin on hamster and rat embryos

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Hepatitis C virus infection: quality of life and side effects of treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00505.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2006.00505.X

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33234511&oldid=1644996834"